Tema Cardiovascular and Metabolics ETF (NASDAQ:HRTS – Get Free Report) was the recipient of a large decrease in short interest during the month of March. As of March 15th, there was short interest totalling 500 shares, a decrease of 28.6% from the February 28th total of 700 shares. Approximately 0.0% of the company’s stock are short sold. Based on an average daily volume of 14,200 shares, the days-to-cover ratio is currently 0.0 days.
Tema Cardiovascular and Metabolics ETF Price Performance
HRTS opened at $29.33 on Tuesday. The firm has a market capitalization of $67.46 million, a PE ratio of 30.61 and a beta of 0.93. The business’s 50-day moving average is $30.14 and its two-hundred day moving average is $31.34. Tema Cardiovascular and Metabolics ETF has a 1 year low of $28.56 and a 1 year high of $36.03.
Institutional Trading of Tema Cardiovascular and Metabolics ETF
A hedge fund recently raised its stake in Tema Cardiovascular and Metabolics ETF stock. Sterling Investment Advisors Ltd. raised its position in Tema Cardiovascular and Metabolics ETF (NASDAQ:HRTS – Free Report) by 5.7% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 167,703 shares of the company’s stock after acquiring an additional 9,008 shares during the period. Tema Cardiovascular and Metabolics ETF makes up approximately 1.2% of Sterling Investment Advisors Ltd.’s holdings, making the stock its 24th biggest holding. Sterling Investment Advisors Ltd. owned 7.29% of Tema Cardiovascular and Metabolics ETF worth $4,842,000 at the end of the most recent quarter.
About Tema Cardiovascular and Metabolics ETF
The Tema Obesity & Cardiometabolic ETF (HRTS) is an exchange-traded fund that mostly invests in health care equity. The fund is an actively managed fund that concentrates on companies focused on the treatment of cardiovascular diseases and/or metabolic diseases from companies all around the world. Using both top-down and bottom-up stock selection, the fund identifies innovative companies deemed attractive.
Read More
- Five stocks we like better than Tema Cardiovascular and Metabolics ETF
- Breakout Stocks: What They Are and How to Identify Them
- 3 Buyable Stocks With Solid Bottoms Ready to Rebound
- What Are the FAANG Stocks and Are They Good Investments?
- Advantage+ Shopping: Meta’s Fast Growing $20 Billion AI-Ads Star
- Canadian Penny Stocks: Can They Make You Rich?
- Robotaxi News: What Tesla and Lyft Headlines Mean for Shares
Receive News & Ratings for Tema Cardiovascular and Metabolics ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tema Cardiovascular and Metabolics ETF and related companies with MarketBeat.com's FREE daily email newsletter.
